Jean‐Jacques Lafitte
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Cystic Fibrosis Research Advances
-
- Radiomics and Machine Learning in Medical Imaging
- Medical Imaging Techniques and Applications
Papers in
-
- Lung Cancer Treatments and Mutations 27
- Lung Cancer Diagnosis and Treatment 18
-
- Pharmacogenetics and Drug Metabolism 8
- Co-authors
- Jean‐Paul SculierArnaud ScherpereelThierry BerghmansAnne‐Pascale MeertPhilippe RousselMarianne PaesmansCéline MascauxAnne Tsicopoulos
- Journals
- Lung Cancer (8 papers)Journal of Thoracic Oncology (5 papers)Biochimie (4 papers)European Respiratory Journal (2 papers)Radiology (2 papers)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Jean‐Jacques Lafitte
71 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 122
- Pulmonary and Respiratory Medicine 1.3k
- Radiology, Nuclear Medicine and Imaging 625
- Oncology 672
- Immunology 503
- Pharmacology 161
Countries citing papers authored by Jean‐Jacques Lafitte
This map shows the geographic impact of Jean‐Jacques Lafitte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Jacques Lafitte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Jacques Lafitte more than expected).
Fields of papers citing papers by Jean‐Jacques Lafitte
This network shows the impact of papers produced by Jean‐Jacques Lafitte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Jacques Lafitte. The network helps show where Jean‐Jacques Lafitte may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jean‐Jacques Lafitte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 8 | |
| 2 | Les recommandations de pratique clinique de l'European Lung Cancer Working Party: Mises à jour. | 2014 | 1 |
| 3 | 2012 | 26 | |
| 4 | El valor de captacion estandarizado (SUVmax) del tumor primario medido con tomografia de emission de postrones con fluorodesoxiglucosa (FDG-PET) tiene valor pronostico para la supervivencia en el cancer de pulmon no microcitico (CPNMC): Una revision sistematica y metaanalisis (MA) del European Lung Cancer Working Party para el IASLC Lung Cancer Staging Project | 2008 | 1 |
| 5 | 2008 | 8 | |
| 6 | 2007 | 8 | |
| 7 | 2007 | 19 | |
| 8 | Prognostic role of thyroid transcription factor (TTF-1) in lung cancer: a meta-analysis of the published studies | 2006 | 0 |
| 9 | VEGF et survie des patients atteints d'un cancer pulmonaire. Revue systématique avec méta-analyse. | 2002 | 53 |
| 10 | Citation factors are not reflecting the methodological quality of lung cancer randomised trials. | 2002 | 3 |
| 11 | Haematological colony-stimulating factor (CSF) in the treatment of small-cell lung cancer (SCLC): a systematic review of the literature with meta-analysis. | 2002 | 0 |
| 12 | 2002 | 19 | |
| 13 | 2001 | 202 | |
| 14 | 2000 | 211 | |
| 15 | Prognostic factors analysis for response to chemotherapy and survival in a prospective cohort of patients with unresectable locoregional non small cell lung cancer initially treated by induction chemotherapy | 1999 | 2 |
| 16 | 1999 | 231 | |
| 17 | 1996 | 71 | |
| 18 | 1995 | 33 | |
| 19 | 1991 | 38 | |
| 20 | 1989 | 1 |
About Jean‐Jacques Lafitte
Jean‐Jacques Lafitte is a scholar working on Pulmonary and Respiratory Medicine, Pharmacology, Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 76 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Diagnosis and Treatment (18 papers), Lung Cancer Research Studies (14 papers), Glycosylation and Glycoproteins Research (9 papers), Radiomics and Machine Learning in Medical Imaging (9 papers), Pharmacogenetics and Drug Metabolism (8 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.3k citations), Radiology, Nuclear Medicine and Imaging (625 citations), Oncology (672 citations), Immunology (503 citations) and Pharmacology (161 citations). Jean‐Jacques Lafitte has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Jean‐Paul Sculier, Arnaud Scherpereel, Thierry Berghmans, Anne‐Pascale Meert, Philippe Roussel, Marianne Paesmans, Céline Mascaux, Anne Tsicopoulos, Qutayba Hamid and Martine Roelandts. Their work appears in journals such as Lung Cancer, Journal of Thoracic Oncology, Biochimie, European Respiratory Journal and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.